Literature DB >> 22547215

Gastrointestinal cancer: Salvage chemotherapy in gastric cancer--more than a straw?

Florian Lordick.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22547215     DOI: 10.1038/nrclinonc.2012.76

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


× No keyword cloud information.
  10 in total

1.  The impact of perioperative chemotherapy on survival in patients with gastric signet ring cell adenocarcinoma: a multicenter comparative study.

Authors:  Mathieu Messager; Jérémie H Lefevre; Virginie Pichot-Delahaye; Amine Souadka; Guillaume Piessen; Christophe Mariette
Journal:  Ann Surg       Date:  2011-11       Impact factor: 12.969

2.  Survival advantage for irinotecan versus best supportive care as second-line chemotherapy in gastric cancer--a randomised phase III study of the Arbeitsgemeinschaft Internistische Onkologie (AIO).

Authors:  Peter C Thuss-Patience; Albrecht Kretzschmar; Dmitry Bichev; Tillman Deist; Axel Hinke; Kirstin Breithaupt; Yasemin Dogan; Bernhard Gebauer; Guido Schumacher; Peter Reichardt
Journal:  Eur J Cancer       Date:  2011-10       Impact factor: 9.162

3.  Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world.

Authors:  Farin Kamangar; Graça M Dores; William F Anderson
Journal:  J Clin Oncol       Date:  2006-05-10       Impact factor: 44.544

4.  Early palliative care for patients with metastatic non-small-cell lung cancer.

Authors:  Jennifer S Temel; Joseph A Greer; Alona Muzikansky; Emily R Gallagher; Sonal Admane; Vicki A Jackson; Constance M Dahlin; Craig D Blinderman; Juliet Jacobsen; William F Pirl; J Andrew Billings; Thomas J Lynch
Journal:  N Engl J Med       Date:  2010-08-19       Impact factor: 91.245

Review 5.  Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data.

Authors:  Anna D Wagner; Wilfried Grothe; Johannes Haerting; Gerhard Kleber; Axel Grothey; Wolfgang E Fleig
Journal:  J Clin Oncol       Date:  2006-06-20       Impact factor: 44.544

6.  Intrinsic subtypes of gastric cancer, based on gene expression pattern, predict survival and respond differently to chemotherapy.

Authors:  Iain Beehuat Tan; Tatiana Ivanova; Kiat Hon Lim; Chee Wee Ong; Niantao Deng; Julian Lee; Sze Huey Tan; Jeanie Wu; Ming Hui Lee; Chia Huey Ooi; Sun Young Rha; Wai Keong Wong; Alex Boussioutas; Khay Guan Yeoh; Jimmy So; Wei Peng Yong; Akira Tsuburaya; Heike Grabsch; Han Chong Toh; Steven Rozen; Jae Ho Cheong; Sung Hoon Noh; Wei Kiat Wan; Jaffer A Ajani; Ju-Seog Lee; Manuel Salto Tellez; Patrick Tan
Journal:  Gastroenterology       Date:  2011-04-28       Impact factor: 22.682

7.  Comparison of gastric cancer survival following R0 resection in the United States and Korea using an internationally validated nomogram.

Authors:  Vivian E Strong; Kyo Young Song; Cho Hyun Park; Lindsay M Jacks; Mithat Gonen; Manish Shah; Daniel G Coit; Murray F Brennan
Journal:  Ann Surg       Date:  2010-04       Impact factor: 12.969

8.  Cancer statistics, 2012.

Authors:  Rebecca Siegel; Deepa Naishadham; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2012-01-04       Impact factor: 508.702

9.  Salvage chemotherapy for pretreated gastric cancer: a randomized phase III trial comparing chemotherapy plus best supportive care with best supportive care alone.

Authors:  Jung Hun Kang; Soon Il Lee; Do Hyoung Lim; Keon-Woo Park; Sung Yong Oh; Hyuk-Chan Kwon; In Gyu Hwang; Sang-Cheol Lee; Eunmi Nam; Dong Bok Shin; Jeeyun Lee; Joon Oh Park; Young Suk Park; Ho Yeong Lim; Won Ki Kang; Se Hoon Park
Journal:  J Clin Oncol       Date:  2012-03-12       Impact factor: 44.544

10.  S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial.

Authors:  Wasaburo Koizumi; Hiroyuki Narahara; Takuo Hara; Akinori Takagane; Toshikazu Akiya; Masakazu Takagi; Kosei Miyashita; Takashi Nishizaki; Osamu Kobayashi; Wataru Takiyama; Yasushi Toh; Takashi Nagaie; Seiichi Takagi; Yoshitaka Yamamura; Kimihiko Yanaoka; Hiroyuki Orita; Masahiro Takeuchi
Journal:  Lancet Oncol       Date:  2008-02-20       Impact factor: 41.316

  10 in total
  4 in total

1.  Gastrointestinal cancer. Over the RAINBOW--renaissance in antiangiogenesis.

Authors:  Florian Lordick
Journal:  Nat Rev Clin Oncol       Date:  2014-11-18       Impact factor: 66.675

2.  [Treatment of gastric cancer].

Authors:  F Lordick; A Hoffmeister
Journal:  Internist (Berl)       Date:  2014-01       Impact factor: 0.743

Review 3.  Optimal chemotherapy for advanced gastric cancer: is there a global consensus?

Authors:  Florian Lordick; Sylvie Lorenzen; Yasuhide Yamada; David Ilson
Journal:  Gastric Cancer       Date:  2013-09-19       Impact factor: 7.370

Review 4.  Onivyde for the therapy of multiple solid tumors.

Authors:  Haijun Zhang
Journal:  Onco Targets Ther       Date:  2016-05-20       Impact factor: 4.147

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.